KPV is the C-terminal tripeptide fragment (amino acids 11–13) of the α-melanocyte-stimulating hormone (α-MSH) sequence. This short peptide retains key regulatory signaling characteristics associated with the parent hormone while lacking the melanotropic activity linked to pigmentation pathways.
In experimental literature, KPV is primarily examined for its interaction with inflammatory signaling networks, particularly pathways associated with NF-κB activation and cytokine regulation.
Cellular Uptake
In experimental models involving intestinal epithelial and immune cells, KPV can be transported intracellularly via the PepT1 (hPepT1) oligopeptide transporter. This transporter is often upregulated in inflamed intestinal tissues and facilitates the uptake of small di- and tripeptides across epithelial barriers.
Because of this transporter interaction, KPV is frequently investigated in research examining intestinal peptide absorption and mucosal immune signaling.
NF-κB Pathway Interaction
One of the most widely discussed mechanisms of KPV in experimental literature involves its interaction with the NF-κB signaling pathway, a central regulator of inflammatory gene transcription.
Research observations suggest several molecular interactions:
• IκBα stabilization – KPV has been associated with delayed degradation and accelerated recovery of IκBα, the inhibitory protein that retains NF-κB in the cytoplasm.
• Nuclear translocation modulation – experimental data indicate that KPV may interfere with the interaction between the p65RelA NF-κB subunit and nuclear transport proteins such as importin-α3. This interaction can influence NF-κB nuclear translocation dynamics.
• Reduced NF-κB signaling duration – rather than fully suppressing the pathway, KPV is associated with modulation of NF-κB activation dynamics.
Downstream effects reported in experimental studies include changes in transcription of cytokine-related genes such as:
TNF-α
IL-1β
IL-6
IL-8
MCP-1
These observations have made KPV a subject of interest in research examining cytokine-mediated signaling networks.
Beyond NF-κB-related signaling, some experimental models have reported interactions between KPV and MAPK signaling cascades, including:
ERK1/2
JNK
p38
These pathways are frequently investigated in studies examining cellular stress responses, cytokine signaling, and inflammatory pathway regulation.
In certain cell systems, particularly airway or skin models, limited evidence suggests involvement of melanocortin receptors such as MC3R, although many reported effects appear independent of classical melanocortin receptor activation.
Intestinal Inflammation Models
KPV is frequently investigated in preclinical intestinal inflammation models, including DSS and TNBS-induced colitis systems. In these models, experimental observations have reported changes in cytokine signaling, neutrophil infiltration, and inflammatory pathway activity.
Because KPV interacts with the PepT1 transporter in intestinal tissue, it is commonly examined in research exploring:
epithelial barrier signaling
mucosal immune regulation
intestinal cytokine networks
peptide transporter dynamics
Skin and Cellular Inflammatory Signaling
Cell culture studies have reported that KPV can influence TNF-α-mediated signaling and ICAM-1 expression in dermal fibroblasts and keratinocytes.
These mechanisms are typically examined in laboratory models studying inflammatory signaling pathways in skin and epithelial tissues.
Neuroimmune and Gut–Brain Axis Research
Interactions between intestinal immune signaling and the nervous system are increasingly investigated in gut–brain axis research.
Changes in cytokine signaling and epithelial barrier dynamics may influence vagal nerve pathways and systemic inflammatory signaling. Within this framework, peptides derived from melanocortin signaling systems, including KPV, are occasionally examined in experimental models investigating neuroimmune communication.
Due to its small tripeptide structure, KPV is capable of interacting with peptide transport systems such as PepT1, which mediates the uptake of small peptides in the intestinal epithelium.
For this reason, oral capsule formats are often used in experimental settings investigating intestinal peptide transport and localized mucosal signaling.
KPV is widely studied in research models focused on inflammation signaling and epithelial cellular environments, particularly within gut-associated systems. Its interaction with pathways such as NF-κB makes it relevant in studies exploring how localized inflammation and cellular communication are regulated.
To see how KPV is examined alongside other compounds in gut and immune signaling research:
→ Gut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1
For a deeper scientific overview of its mechanism, pathways, and research applications:
→ What is KPV? - NF-κB Signaling and Inflammation Research Explained
Synonyms: Lys-Pro-Val peptide, KPV peptide
Molecular Formula: C16H30N4O4
Molecular Weight: 342.43 g/mol
CAS: 67727-97-3
Experimental studies have discussed KPV in relation to:
NF-κB signaling pathways
cytokine regulation networks
epithelial barrier biology
melanocortin-related peptide signaling
intestinal transporter systems
neuroimmune communication models
KPV Structures:
In vitro research or further manufacturing use only. Not for human or animal use.
All information provided by PRG is for educational and informational purposes only.
Best Practices for Storing Peptides
To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.
Preventing Oxidation & Moisture Damage
Peptides can be compromised by exposure to moisture and air—especially immediately after removal from a freezer.
Storing Peptides in Solution
Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.
Containers for Peptide Storage
Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.
Regenesis Peptide Storage Quick Tips
